Trial Details
COMPLETEDBasic Information
| Clinical ID | c3813 |
|---|---|
| Identifier | NCT01494233 |
| Trial Title | A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: 250 mg LX1033 tablets|DRUG: Placebo tablet |
Participant Information
| Sponsor | Lexicon Pharmaceuticals |
|---|---|
| City | Huntsville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2012-02 |
|---|---|
| Primary Completion Date | 2013-09 |
| Completion Date | - |